Search Results - "Biron, Amelie"

Histological Indices and Risk of Recurrence in Crohn’s Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission by Lirsac, Marion, Biron, Amélie, Djerada, Zoubir, Cadiot, Guillaume, Morcos-Sauvain, Elise, Brixi, Hedia, Le Saint, Margaux, Marchal, Aude, Boulagnon-Rombi, Camille

“…Abstract Background Although histological healing is raising interest in ulcerative colitis to predict recurrence, its meaning in Crohn’s disease (CD) remains…”
Get full text

Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study by Fumery, Mathurin, Filippi, Jérôme, Abitbol, Vered, Biron, Amélie, Laharie, David, Serrero, Melanie, Altwegg, Romain, Bouhnik, Yoram, Peyrin‐Biroulet, Laurent, Gilletta, Cyrielle, Roblin, Xavier, Pineton de Chambrun, Guillaume, Vuitton, Lucine, Bourrier, Anne, Nancey, Stephane, Gornet, Jean‐Marc, Nahon, Stephane, Bouguen, Guillaume, Viennot, Stephanie, Nachury, Maria, Amiot, Aurelien, Brazier, Franck, Yzet, Clara, Hebuterne, Xavier, Cadiot, Guillaume, Brixi, Hedia, Rivière, Pauline, Poullenot, Florian, Treton, Xavier, Stefanescu, Carmen, Zallot, Camille, Beaugerie, Laurent, Seksik, Philippe, Sokol, Harry, Kirchgesner, Julien, Boschetti, Gilles, Flourié, Bernard, Gay, Claire, Danion, Pauline, Venturin, Chloe, Allez, Matthieu, Baudry, Clotilde, Pariente, Benjamin, Wils, Pauline, Gagnière, Charlotte, Tannoury, Jenny

“…Summary Background Phase III trials have demonstrated the efficacy and safety of ustekinumab in ulcerative colitis (UC), but few real‐life long‐term data are…”
Get full text

Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study by Guillo, Lucas, Amiot, Aurélien, Serrero, Mélanie, Altwegg, Romain, Roblin, Xavier, Atanasiu, Calina, Buisson, Anthony, Le Berre, Catherine, Reenaers, Catherine, Gornet, Jean-Marc, Laharie, David, Abitbol, Vered, Biron, Amélie, Caron, Bénédicte, Nancey, Stéphane, Chupin, Antoine, Blain, Antoine, Vuitton, Lucine, Caillo, Ludovic, Kirchgesner, Julien, Nachury, Maria, Peyrin-Biroulet, Laurent

“…Background and Aims Patients with inflammatory bowel disease have an increased risk of venous thromboembolism (VTE) and cardiovascular disease (CVD). The study…”
Get full text

Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease by Biron, Amélie, Beaugerie, Laurent, Chazouillères, Olivier, Kirchgesner, Julien

“…Summary Background Patients with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) are at risk of biliary tract cancer and liver damage…”
Get full text

Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study) by Laharie, David, Bouhnik, Yoram, Vuitton, Lucine, Biron, Amélie, Pierron, Gaelle, Brault, Yves, Assing, Maryse, Bouzidi, Amira, Amiot, Aurélien, Nancey, Stephane

“…•ReFLECT provides real-life data on the safety and effectiveness of IV CT-P13 in IBD.•CT-P13 effectiveness was maintained in >80 % of IFX-switched patients…”
Get full text

Diagnosis of postoperative recurrence of Crohn disease with MR-enterography: Value of diffusion-weighted imaging by Djelouah, Manel, Marical, Victoria, Kanagaratnam, Lukshe, Kianmanesh, Reza, Biron, Amélie, Cadiot, Guillaume, Hoeffel, Christine

“…•Diffusion-weighted MR-enterography has similar diagnostic capabilities than contrast-enhanced MR-enterography for the diagnosis of Crohn disease recurrence in…”
Get full text

External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab by Konecki, Celine, Feliu, Catherine, Cazaubon, Yoann, Giusti, Delphine, Tonye-Libyh, Marcelle, Brixi, Hedia, Cadiot, Guillaume, Biron, Amélie, Djerada, Zoubir

“…Despite the well-demonstrated efficacy of infliximab in inflammatory diseases, treatment failure remains frequent. Dose adjustment using Bayesian methods has…”
Get full text

Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID by Caron, Bénédicte, Seksik, Philippe, Buisson, Anthony, Wils, Pauline, Savoye, Guillaume, Stefanescu, Carmen, Laharie, David, Guillo, Lucas, Abitbol, Vered, Bonnet, Joelle, Altwegg, Romain, Vuitton, Lucine, Moussata, Driffa, Bourreille, Arnaud, Biron, Amélie, Gilletta, Cyrielle, Fumery, Mathurin, Nahon, Stephane, Nancey, Stephane, Camara, Houda, Peyrin-Biroulet, Laurent

“…Several adalimumab preparations are now available for patients with inflammatory bowel disease (IBD). Comparative satisfaction and tolerability are unknown…”
Get full text

1179 PERSISTENCE, EFFICACY AND TOLERANCE OF SUBCUTANEOUS INFLIXIMAB AFTER SWITCH FROM INTRAVENOUS INFLIXIMAB IN IBD PATIENTS IN REMISSION:: ONE-TEAR RESULTS FROM A MULTICENTER PROSPECTIVE COHORT by Mathieu, Nicolas, Heluwaert, Frédéric, Rivière, Pauline, Hebuterne, Xavier, Chupin, Antoine, Abitbol, Vered, Guillaume, Bouguen, Vuitton, Lucine, Allez, Matthieu, Montuclard, Celine, Nancey, Stephane, Biron, Amelie, Wils, Pauline, Gilletta, Cyrielle, de Maissin, Astrid, Altwegg, Romain, Chanteloup, Elise, Plastaras, Laurianne, Soune, Philippe Ah, Bourreille, Arnaud, Bouhnik, Yoram, Seksik, Philippe, Simon, Marion, Uzzan, Mathieu, andrau, Pierre, Rouillon, Clea, Arondel, Yves, Peyrin-Biroulet, Laurent, Laharie, David, Vicaut, Eric, Hupé, Marianne

Get full text

Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study by Fumery, Mathurin, Defrance, Antoine, Roblin, Xavier, Altwegg, Romain, Caron, Benedicte, Hébuterne, Xavier, Stefanescu, Carmen, Meyer, Antoine, Nachury, Maria, Laharie, David, Nancey, Stephane, Le Berre, Catherine, Serrero, Melanie, Geyl, Sophie, Giletta, Cyrielle, Ah‐Soune, Philippe, Duveau, Nicolas, Uzzan, Mathieu, Abitbol, Vered, Biron, Amelie, Tran‐Minh, My‐Linh, Paupard, Thierry, Vuitton, Lucine, Elgharabawy, Yasmine, Peyrin‐Biroulet, Laurent

“…Summary Background Phase III trials have demonstrated the efficacy of risankizumab in moderate‐to‐severe Crohn's disease (CD), but no real‐world data are…”
Get full text

Tu1768 PERSISTENCE OF SUBCUTANEOUS INFLIXIMAB AFTER SWITCHING FROM INTRAVENOUS IN A FRENCH NATIONAL COHORT OF IBD PATIENTS IN REMISSION by Mathieu, Nicolas, Rivière, Pauline, Heluwaert, Frédéric, Hebuterne, Xavier, Chupin, Antoine, Guillaume, Bouguen, Vuitton, Lucine, Allez, Matthieu, montuclard, celine, Nachury, Maria, Nancey, Stephane, Biron, Amelie, Giletta, Cyrielle, Abitbol, Vered, Altwegg, Romain, de maissin, astrid, Plastaras, Laurianne, Soune, Philippe Ah, Bourreille, Arnaud, Bouhnik, Yoram, Seksik, Philippe, chanteloup, Elise, Simon, Marion, Uzzan, Mathieu, andrau, Pierre, Rouillon, Clea, arondel, yves, Peyrin-Biroulet, Laurent, Laharie, David

Get full text

Sa1820 RISK OF INCIDENT CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE WITH PRIOR BREAST CANCER : A MULTICENTRE COHORT STUDY by Cosquer, Guillaume Le, Gilletta, Cyrielle, Amiot, Aurelien, Rivière, Pauline, Nachury, Maria, Rouillon, Clea, Bouhnik, Yoram, Abitbol, Vered, Nancey, Stephane, Fumery, Mathurin, Savoye, Guillaume, Biron, Amelie, Picon, Laurence, Peyrin-Biroulet, Laurent, Vidon, M.M., Reenaers, Catherine, Simon, Marion, Caron, Bénédicte, Serrero, Melanie, Altwegg, Romain, BENEZECH, Alban, Goutorbe, Felix, Rahier, Jean-Francois, Beaugerie, Laurent, Pelletier, Anne-Laure, Caillo, Ludovic, Laharie, David, Poullenot, Florian

Get full text

Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS by Vuitton, Lucine, Bourrier, Anne, Uzzan, Mathieu, Nachury, Maria, Amiot, Aurelien, Roblin, Xavier, Allez, Matthieu, Altwegg, Romain, Vidon, M.M., Bourreille, Arnaud, Serrero, Melanie, Pelletier, Anne-Laure, Filippi, Jerome, Gilletta, Cyrielle, Simon, Marion, Laharie, David, Nahon, Stephane, Duveau, Nicolas, Biron, Amelie, Viennot, Stephanie, Abitbol, Vered, Elgharabawy, Yasmine, Peyrin-Biroulet, Laurent

Get full text

Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID by Amiot, Aurelien, Laharie, David, Malamut, Georgia, Serrero, Melanie, Poullenot, Florian, Peyrin-Biroulet, Laurent, Laharie, David , Bourreille, Arnaud, Vuitton, Lucine, Bouguen, Guillaume, Abitbol, Vered, Amiot, Aurelien , Biron, Amelie, Bourrier, Anne, Caillo, Ludovic, Fumery, Mathurin, Gilletta, Cyrielle, Plastaras, Laurianne, Serrero, Melanie, Simon, Marion, Viennot, Stephanie, Seksik, Philippe, Attar, Alain, Buisson, Anthony, Caron, Benedicte, Charkaoui, Maeva, Gornet, Jean-Marc, Guillo, Lucas, Berre, Catherine Le, Louis, Edouard, Malamut, Georgia, Mathieu, Nicolas, Nachury, Maria, Nancey, Stephane, Paul, Stephane, Reenaers, Catherine, Treton, Xavier, Uzzan, Mathieu, Wils, Pauline

“…There is no consensus on the management of immune checkpoint inhibitor (ICI) for treating cancer in patients with pre-existing inflammatory bowel disease…”
Get full text

Long-term Outcome of Risankizumab in Crohn’s Disease: a Real-world GETAID Study by Fumery, Mathurin, Caron, Benedicte, Hébuterne, Xavier, Altwegg, Romain, Roblin, Xavier, Stefanescu, Carmen, Meyer, Antoine, Nachury, Maria, Laharie, David, Le Berre, Catherine, Guillo, Lucas, Biron, Amélie, Caillo, Ludovic, Buisson, Anthony, Nancey, Stephane, Uzzan, Mathieu, Vuitton, Lucine, Gilletta, Cyrielle, Geyl, Sophie, Blain, Antoine, Kirchgesner, Julien, Ah-Soune, Philippe, Duveau, Nicolas, Vidon, Mathias, Abitbol, Vered, Paupard, Thierry, Tran-Minh, My-Linh, Defrance, Antoine, Peyrin-Biroulet, Laurent

“…The aim of this study was to assess the long-term effectiveness and safety of risankizumab maintenance treatment in a large real-world cohort of patients with…”
Get full text

Risk of incident cancer in patients with Inflammatory Bowel Disease with prior breast cancer: a multicenter cohort study by Le Cosquer, Guillaume, Kirchgesner, Julien, Gilletta De Saint Joseph, Cyrielle, Seksik, Philippe, Amiot, Aurélien, laharie, david, nachury, maria, rouillon, cléa, abitbol, vered, nuzzo, alexandre, nancey, stéphane, fumery, mathurin, biron, amélie, richard, nicolas, altwegg, romain, moussata, driffa, caron, benedicte, vidon, mathias, reenaers, catherine, uzzan, mathieu, reimund, Jean-marie, serrero, mélanie, simon, marion, benezech, alban, goutorbe, félix, pelletier, Anne-laure, caillo, ludovic, vaysse, charlotte, poullenot, florian

“…Breast cancer is the most common malignancy observed in patients with inflammatory bowel diseases (IBD). The aim of our study was to evaluate incident cancer…”
Get full text